Interpace Biosciences (IDXG) Competitors

Laboratory Co. of America (NYSE:LH) and Interpace Biosciences (NASDAQ:IDXG) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, earnings, dividends, media sentiment, profitability, risk, community ranking and valuation.

Does the media favor LH or IDXG?

In the previous week, Laboratory Co. of America had 9 more articles in the media than Interpace Biosciences. MarketBeat recorded 9 mentions for Laboratory Co. of America and 0 mentions for Interpace Biosciences. Laboratory Co. of America's average media sentiment score of 1.38 beat Interpace Biosciences' score of 0.00 indicating that Laboratory Co. of America is being referred to more favorably in the media.

Company	Overall Sentiment
Laboratory Co. of America	Positive
Interpace Biosciences	Neutral

Which has more risk and volatility, LH or IDXG?

Laboratory Co. of America has a beta of 1.06, suggesting that its stock price is 6% more volatile than the S&P 500. Comparatively, Interpace Biosciences has a beta of 0.77, suggesting that its stock price is 23% less volatile than the S&P 500.

Do analysts recommend LH or IDXG?

Laboratory Co. of America currently has a consensus price target of $260.54, suggesting a potential upside of 6.50%. Given Laboratory Co. of America's stronger consensus rating and higher probable upside, research analysts plainly believe Laboratory Co. of America is more favorable than Interpace Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Laboratory Co. of America	0 Sell rating(s)	3 Hold rating(s)	12 Buy rating(s)	1 Strong Buy rating(s)	2.88
Interpace Biosciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Which has better earnings and valuation, LH or IDXG?

Laboratory Co. of America has higher revenue and earnings than Interpace Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Laboratory Co. of America	$12.16B	1.68	$418M	$5.17	47.32
Interpace Biosciences	$40.21M	0.10	$800K	N/A	N/A

Does the MarketBeat Community believe in LH or IDXG?

Laboratory Co. of America received 300 more outperform votes than Interpace Biosciences when rated by MarketBeat users. However, 72.83% of users gave Interpace Biosciences an outperform vote while only 64.08% of users gave Laboratory Co. of America an outperform vote.

Company	Underperform	Outperform
Laboratory Co. of America	Outperform Votes 619 64.08%	Underperform Votes 347 35.92%
Interpace Biosciences	Outperform Votes 319 72.83%	Underperform Votes 119 27.17%

Do institutionals & insiders hold more shares of LH or IDXG?

95.9% of Laboratory Co. of America shares are held by institutional investors. Comparatively, 5.7% of Interpace Biosciences shares are held by institutional investors. 0.9% of Laboratory Co. of America shares are held by company insiders. Comparatively, 5.5% of Interpace Biosciences shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Is LH or IDXG more profitable?

Interpace Biosciences has a net margin of 10.39% compared to Laboratory Co. of America's net margin of 3.43%. Laboratory Co. of America's return on equity of 15.27% beat Interpace Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Laboratory Co. of America	3.43%	15.27%	7.13%
Interpace Biosciences	10.39%	-8.09%	37.14%

Summary

Laboratory Co. of America beats Interpace Biosciences on 13 of the 17 factors compared between the two stocks.